The MarketReader Minute
💊 TG Therapeutics Soars on Q4 Results; Moderna Faces Scrutiny Over Contract Review | Biotech Sector Insights
(IBB) has seen a price movement of -0.5% since Friday. Among the ETF's holdings, Fortrea Holdings reported fourth-quarter financials that fell short of expectations, contributing to negative performance from several key stocks.